1-3 of 3
R. Scott Pearsall
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Endothelial ALK1 Is a Therapeutic Target to Block Metastatic Dissemination of Breast Cancer

Sara I. Cunha, Matteo Bocci, John Lövrot, Nikolas Eleftheriou, Pernilla Roswall, Eugenia Cordero, Linda Lindström, Michael Bartoschek, B. Kristian Haller, R. Scott Pearsall, Aaron W. Mulivor, Ravindra Kumar, Christer Larsson, Jonas Bergh, Kristian Pietras
Journal: Cancer Research
Series: Author Choice
Cancer Res (2015) 75 (12): 2445–2456.
https://doi.org/10.1158/0008-5472.CAN-14-3706
Published: 14 June 2015
View article titled, Endothelial ALK1 Is a Therapeutic Target to Block Metastatic Dissemination of Breast Cancer
Open the PDF for Endothelial ALK1 Is a Therapeutic Target to Block Metastatic Dissemination of Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract 5080: Inhibiting the ALK1/BMP9 signaling pathway with dalantercept as an antiangiogenic therapy.

Marat Alimzhanov, Nicolas Solban, Michael Lee, Phaethon Philbrook, Xiaoen Wang, Lin Wei, Jiaxi Song, Sabina Signoretti, R. Scott Pearsall, Matthew L. Sherman, Ravindra Kumar, Rupal S. Bhatt
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 5080.
https://doi.org/10.1158/1538-7445.AM2013-5080
Published: 15 April 2013
View article titled, Abstract 5080: Inhibiting the ALK1/BMP9 signaling pathway with dalantercept as an antiangiogenic therapy.
Journal Articles

Abstract LB-313: ALK1-Fc inhibits tumor growth in a VEGF pathway resistance model of renal cell carcinoma

Xiaoen Wang, Nicolas Solban, Manoj K. Bhasin, Brittany Bahamon, Liang Zhang, Sabina Signoretti, David C. Alsop, Michael B. Atkins, R. Scott Pearsall, James W. Mier, Ravindra Kumar, Rupal S. Bhatt
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): LB-313.
https://doi.org/10.1158/1538-7445.AM2012-LB-313
Published: 15 April 2012
View article titled, Abstract LB-313: ALK1-Fc inhibits tumor growth in a VEGF pathway resistance model of renal cell carcinoma